137 results
Page 3 of 7
8-K
EX-99.1
l5n9m0hlye ckiuziu
1 Dec 14
Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99
k092q ripb
17 Oct 14
Other Events
12:00am
8-K
EX-99.1
am4 mku0pllwn2imw
9 Jul 14
Anoro® Ellipta® (umeclidinium/vilanterol) approved in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.1
pekawce
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
clipgk7
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
6m40ymo8sscl
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.2
7r732in
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.5
4l95 vczth4k28jv20
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-99
2li0q
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
xoc7al4riwx5f
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.4
alds1q4 1g5dwmk7u
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
5hm9 dd2yv
9 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99
r2a9h
6 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
hhrcxkji2181rq
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am